Erin Kissane, a co-founder of the COVID Tracking Project, rolled up her sleeve for the Novavax COVID-19 vaccine in mid-October soon after it was finally recommended in the United States.
Erin Kissane, a co-founder of the COVID Tracking Project, rolled up her sleeve for the Novavax covid-19 vaccine in mid-October soon after it was finally recommended in the United States.
People with special medical considerations are hoping the Novavax shot will bring fewer headaches, fevers, and less fatigue than have been reported by those taking mRNA vaccines.
People with special medical considerations are hoping the Novavax shot will bring fewer headaches, fevers, and less fatigue than have been reported by those taking mRNA vaccines.